Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study

Cristina Rigamonti, Micol Giulia Cittone, Carla De Benedittis, Eleonora Rizzi, Giuseppe Francesco Casciaro, Mattia Bellan, Pier Paolo Sainaghi, Mario Pirisi

Risultato della ricerca: Contributo su rivistaBreve indaginepeer review

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus responsible for a variety of clinical manifestations that, besides the lungs, can involve several other organs, leading to both mild and severe complications.1–3

Lingua originaleInglese
pagine (da-a)2369-2371.e1
RivistaClinical Gastroenterology and Hepatology
Volume18
Numero di pubblicazione10
DOI
Stato di pubblicazionePubblicato - set 2020

Fingerprint

Entra nei temi di ricerca di 'Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study'. Insieme formano una fingerprint unica.

Cita questo